Varian Medical Systems Inc. said it received clearances from the U.S. antitrust authorities and the German Federal Cartel Office for the proposed acquisition of Sirtex Medical Ltd.
Palo Alto, Calif.-based Varian Medical had agreed to buy the Australian life sciences company for A$1.59 billion.
The transaction, which is expected to close in late May, is still subject to the approval of the Sirtex shareholders, the Federal Court of Australia and other customary closing conditions, including other applicable regulatory approvals.
